FRTX

Fresh Tracks Therapeutics, Inc. Common Stock

FRTX

市值 US$472萬

已下市

FRTX已於2023年12月18日下市。

關於： Fresh Tracks Therapeutics Inc is a clinical-stage pharmaceutical company striving to transform patient lives through the development of innovative and differentiated prescription therapeutics.

員工： 13

醫療保健藥品製造商－一般

新聞

正面

中性

負面

市場情緒 3個月

正面 0%

中性 0%

負面 0%

中性

GlobeNewsWire

2 年前

Fresh Tracks Therapeutics Announces its Common Stock will be Suspended from Trading on Nasdaq at Open of Business on December 19th

Common stock expected to begin trading on over-the-counter market following suspension Common stock expected to begin trading on over-the-counter market following suspension

中性

GlobeNewsWire

2 年前

Fresh Tracks Therapeutics Announces Third Adjournment of Special Meeting of Stockholders

Meeting adjourned to December 27, 2023 at 10 a.m. MT

中性

GlobeNewsWire

2 年前

Fresh Tracks Therapeutics Announces Second Adjournment of Special Meeting of Stockholders

Meeting adjourned to December 15, 2023 at 10 a.m. MT

中性

GlobeNewsWire

2 年前

Fresh Tracks Therapeutics Announces Adjournment of Special Meeting of Stockholders

Meeting adjourned to November 30, 2023 at 10 a.m. MT Fresh Tracks encourages all stockholders of record on October 17, 2023 who have not yet voted to do so by 11:59 p.m.

查看新聞排名

價格圖表採用Lightweight Charts™實作

Fresh Tracks Therapeutics, Inc. Common Stock FRTX 市值 US$472萬

新聞

Fresh Tracks Therapeutics, Inc. Common Stock

FRTX

市值 US$472萬